Literature DB >> 23428180

Variation in tau isoform expression in different brain regions and disease states.

Elisa Majounie1, William Cross, Victoria Newsway, Allissa Dillman, Jana Vandrovcova, Christopher M Morris, Michael A Nalls, Luigi Ferrucci, Michael J Owen, Michael C O'Donovan, Mark R Cookson, Andrew B Singleton, Rohan de Silva, Huw R Morris.   

Abstract

Progressive supranuclear palsy (PSP) is the most common atypical parkinsonian disorder. Abnormal tau inclusions, in selected regions of the brain, are a hallmark of the disease and the H1 haplotype of MAPT, the gene encoding tau, is the major risk factor in PSP. A 3-repeat and 4-repeat (4R) tau isoform ratio imbalance has been strongly implicated as a cause of disease. Thus, understanding tau isoform regional expression in disease and pathology-free states is crucial to elucidating the mechanisms involved in PSP and other tauopathies. We used a tau isoform-specific fluorescent assay to investigate relative 4R-tau expression in 6 different brain regions in PSP cases and healthy control samples. We identified a marked difference in 4R-tau relative expression, across brain regions and between MAPT haplotypes. Highest 4R-tau expression levels were identified in the globus pallidus compared with pons, cerebellum, and frontal cortex. 4R-tau expression levels were related to the MAPT H1 and H1c haplotypes. Similar regional variation was seen in PSP case and in control samples.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23428180      PMCID: PMC3642280          DOI: 10.1016/j.neurobiolaging.2013.01.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  22 in total

1.  The H1c haplotype at the MAPT locus is associated with Alzheimer's disease.

Authors:  A J Myers; M Kaleem; L Marlowe; A M Pittman; A J Lees; H C Fung; J Duckworth; D Leung; A Gibson; C M Morris; R de Silva; J Hardy
Journal:  Hum Mol Genet       Date:  2005-07-06       Impact factor: 6.150

2.  High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy.

Authors:  Rosa Rademakers; Stacey Melquist; Marc Cruts; Jessie Theuns; Jurgen Del-Favero; Parvoneh Poorkaj; Matt Baker; Kristel Sleegers; Richard Crook; Tim De Pooter; Samira Bel Kacem; Jennifer Adamson; Dirk Van den Bossche; Marleen Van den Broeck; Jennifer Gass; Ellen Corsmit; Peter De Rijk; Natalie Thomas; Sebastiaan Engelborghs; Michael Heckman; Irene Litvan; Julia Crook; Peter P De Deyn; Dennis Dickson; Gerard D Schellenberg; Christine Van Broeckhoven; Michael L Hutton
Journal:  Hum Mol Genet       Date:  2005-09-29       Impact factor: 6.150

3.  GSK3B polymorphisms alter transcription and splicing in Parkinson's disease.

Authors:  John B J Kwok; Marianne Hallupp; Clement T Loy; Daniel K Y Chan; Jean Woo; George D Mellick; Daniel D Buchanan; Peter A Silburn; Glenda M Halliday; Peter R Schofield
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

4.  Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.

Authors:  Masashi Takanashi; Hideo Mori; Kunimasa Arima; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Brain Res Mol Brain Res       Date:  2002-08-15

5.  Three repeat isoforms of tau inhibit assembly of four repeat tau filaments.

Authors:  Stephanie J Adams; Michael A DeTure; Melinda McBride; Dennis W Dickson; Leonard Petrucelli
Journal:  PLoS One       Date:  2010-05-25       Impact factor: 3.240

Review 6.  Progressive supranuclear palsy: pathology and genetics.

Authors:  Dennis W Dickson; Rosa Rademakers; Michael L Hutton
Journal:  Brain Pathol       Date:  2007-01       Impact factor: 6.508

7.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

8.  Linkage disequilibrium fine mapping and haplotype association analysis of the tau gene in progressive supranuclear palsy and corticobasal degeneration.

Authors:  A M Pittman; A J Myers; P Abou-Sleiman; H C Fung; M Kaleem; L Marlowe; J Duckworth; D Leung; D Williams; L Kilford; N Thomas; C M Morris; D Dickson; N W Wood; J Hardy; A J Lees; R de Silva
Journal:  J Med Genet       Date:  2005-03-25       Impact factor: 6.318

9.  The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.

Authors:  Amanda J Myers; Alan M Pittman; Alice S Zhao; Kristen Rohrer; Mona Kaleem; Lauren Marlowe; Andrew Lees; Doris Leung; Ian G McKeith; Robert H Perry; Chris M Morris; John Q Trojanowski; Christopher Clark; Jason Karlawish; Steve Arnold; Mark S Forman; Vivianna Van Deerlin; Rohan de Silva; John Hardy
Journal:  Neurobiol Dis       Date:  2006-12-15       Impact factor: 5.996

10.  Genome-wide association study reveals genetic risk underlying Parkinson's disease.

Authors:  Javier Simón-Sánchez; Claudia Schulte; Jose M Bras; Manu Sharma; J Raphael Gibbs; Daniela Berg; Coro Paisan-Ruiz; Peter Lichtner; Sonja W Scholz; Dena G Hernandez; Rejko Krüger; Monica Federoff; Christine Klein; Alison Goate; Joel Perlmutter; Michael Bonin; Michael A Nalls; Thomas Illig; Christian Gieger; Henry Houlden; Michael Steffens; Michael S Okun; Brad A Racette; Mark R Cookson; Kelly D Foote; Hubert H Fernandez; Bryan J Traynor; Stefan Schreiber; Sampath Arepalli; Ryan Zonozi; Katrina Gwinn; Marcel van der Brug; Grisel Lopez; Stephen J Chanock; Arthur Schatzkin; Yikyung Park; Albert Hollenbeck; Jianjun Gao; Xuemei Huang; Nick W Wood; Delia Lorenz; Günther Deuschl; Honglei Chen; Olaf Riess; John A Hardy; Andrew B Singleton; Thomas Gasser
Journal:  Nat Genet       Date:  2009-11-15       Impact factor: 38.330

View more
  29 in total

Review 1.  Cellular factors modulating the mechanism of tau protein aggregation.

Authors:  Sarah N Fontaine; Jonathan J Sabbagh; Jeremy Baker; Carlos R Martinez-Licha; April Darling; Chad A Dickey
Journal:  Cell Mol Life Sci       Date:  2015-02-11       Impact factor: 9.261

2.  Genome-wide association study identifies MAPT locus influencing human plasma tau levels.

Authors:  Jason Chen; Jin-Tai Yu; Kevin Wojta; Hui-Fu Wang; Henrik Zetterberg; Kaj Blennow; Jennifer S Yokoyama; Michael W Weiner; Joel H Kramer; Howard Rosen; Bruce L Miller; Giovanni Coppola; Adam L Boxer
Journal:  Neurology       Date:  2017-01-18       Impact factor: 9.910

Review 3.  Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease.

Authors:  Ravindran Kumaran; Mark R Cookson
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

4.  [The importance of molecular imaging (PET) in the diagnostics of dementia].

Authors:  M Tscheuschler; M Gebest; F Jessen; A Drzezga
Journal:  Nervenarzt       Date:  2018-07       Impact factor: 1.214

5.  GRASP: analysis of genotype-phenotype results from 1390 genome-wide association studies and corresponding open access database.

Authors:  Richard Leslie; Christopher J O'Donnell; Andrew D Johnson
Journal:  Bioinformatics       Date:  2014-06-15       Impact factor: 6.937

Review 6.  The neurogenetics of atypical parkinsonian disorders.

Authors:  Brent L Fogel; Mary C Clark; Daniel H Geschwind
Journal:  Semin Neurol       Date:  2014-06-25       Impact factor: 3.420

7.  The effect of MAPT haplotype on neocortical Lewy body pathology in Parkinson disease.

Authors:  Daphne Robakis; Etty Cortes; Lorraine N Clark; Jean Paul G Vonsattel; Tuhin Virmani; Roy N Alcalay; John F Crary; Oren A Levy
Journal:  J Neural Transm (Vienna)       Date:  2016-04-20       Impact factor: 3.575

Review 8.  MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies.

Authors:  Catherine Labbé; Michael G Heckman; Oswaldo Lorenzo-Betancor; Alexandra I Soto-Ortolaza; Ronald L Walton; Melissa E Murray; Mariet Allen; Ryan J Uitti; Zbigniew K Wszolek; Glenn E Smith; Kejal Kantarci; David S Knopman; Val J Lowe; Clifford R Jack; Nilüfer Ertekin-Taner; Anhar Hassan; Rodolfo Savica; Ronald C Petersen; Joseph E Parisi; Demetrius M Maraganore; Neill R Graff-Radford; Tanis J Ferman; Bradley F Boeve; Dennis W Dickson; Owen A Ross
Journal:  Alzheimers Dement       Date:  2016-06-07       Impact factor: 21.566

9.  Modeling tau pathology in human stem cell derived neurons.

Authors:  Selina Wray
Journal:  Brain Pathol       Date:  2017-07       Impact factor: 6.508

10.  Tau Isoform Profile in Essential Tremor Diverges From Other Tauopathies.

Authors:  Soong Ho Kim; Kurt Farrell; Stephanie Cosentino; Jean-Paul G Vonsattel; Phyllis L Faust; Etty P Cortes; David A Bennet; Elan D Louis; John F Crary
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-27       Impact factor: 3.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.